Palvella Therapeutics Revenue

Biotechnology Research • Wayne, Pennsylvania, United States • 21-50 Employees

Palvella Therapeutics revenue & valuation

Annual revenue	$3,500,000
Revenue per employee	$107,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$11,200,000
Total funding	$40,300,000

Key Contacts at Palvella Therapeutics

Jennifer Schauble

Senior Director, Cmc & Supply Chain

Elaine Heron

Member Board Of Directors

Melissa Drexel

Director, Clinical Scientist

Jesse Bregman

Associate Director, Clinical Trial Management

Rebecca Monroe Rossi

Director Clinical Operations

Colleen Pellegrini

Associate Director, Clinical Site And Trial Management

George Jenkins

Director

Irene Davis

Director Of Business Development

Company overview

Headquarters	125 Strafford Ave, Suite 360, Wayne, PA 19087, US
Phone number	+14842531460
Website	palvellatx.com
NAICS	541714
SIC	283
Keywords	Biotechnology, Rare Diseases, Lymphatic Malformations, Genetic Skin Conditions
Founded	2015
Employees	21-50
Socials

Palvella Therapeutics Email Formats

Palvella Therapeutics uses 1 email format. The most common is {first name} (e.g., john@palvellatx.com), used 100% of the time.

Format	Example	Percentage
{first name}	john@palvellatx.com	100%

About Palvella Therapeutics

Palvella Therapeutics (NASDAQ: PVLA) is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. The Company is developing a broad pipeline of product candidates based on its patented QTORIN™ platform, with an initial focus on serious, rare genetic skin diseases, many of which are lifelong in nature. Its lead product candidate, QTORIN 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin), is currently in clinical development for microcystic lymphatic malformations (microcystic LMs) and cutaneous venous malformations. For more information, please go to www.palvellatx.com.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Director

C-Suite

Entry

Employees by Department

Palvella Therapeutics has 12 employees across 8 departments.

Departments

Number of employees

Funding Data

Explore Palvella Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-02-05	7	$37,700,000
2024-11-01	9	$2,600,000

Funding Insights

$40,300,000

Total funding amount

$2,600,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Palvella Therapeutics is located in Wayne, Pennsylvania, US.

You can reach Palvella Therapeutics at +14842531460.

Palvella Therapeutics generates an estimated annual revenue of $3,500,000. This revenue figure reflects the company's market position and business performance in its industry.

Palvella Therapeutics has an estimated valuation of $11,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Palvella Therapeutics was founded in 2015, making it 11 years old. The company has established itself as a significant player in its industry over this time.

Palvella Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Palvella Therapeutics has raised a total of $40,300,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.